CoChat

Apolipoprotein E*4 (APOE*4) Genotype Is Associated with Altered Levels of Glutamate Signaling Proteins and Synaptic Coexpression Networks in the Prefrontal Cortex in Mild to Moderate Alzheimer Disease

Open access
Sweet, Robert A., MacDonald, Matthew L., Kirkwood, Caitlin M., Ding, Ying, Schempf, Tadhg, Jones-Laughner, Jackie, Kofler, Julia, Ikonomovic, Milos D., Lopez, Oscar L., Garver, Megan E., Fitz, Nicholas F., Koldamova, Radosveta, Yates, Nathan A. · 2016 · Molecular & Cellular Proteomics
Cited by 37

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

It has been hypothesized that Alzheimer disease (AD) is primarily a disorder of the synapse. However, assessment of the synaptic proteome in AD subjects has been limited to a small number of proteins and often included subjects with end-stage pathology. Protein from prefrontal cortex gray matter of 59 AD subjects with mild to moderate dementia and 12 normal elderly subjects was assayed using targeted mass spectrometry to quantify 191 synaptically expressed proteins. The profile of synaptic protein expression clustered AD subjects into two groups. One of these was characterized by reduced expression of glutamate receptor proteins, significantly increased synaptic protein network coexpression, and associated withApolipoprotein E*4 (APOE*4) carrier status. The second group, by contrast, showed few differences from control subjects. A subset of AD subjects had altered prefrontal cortex synaptic proteostasis for glutamate receptors and their signaling partners. Efforts to therapeutically target glutamate receptors in AD may have outcomes dependent on APOE*4 genotype.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/mcp.m115.056580

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 37

Metadata

Authors
Sweet, R. A., MacDonald, M. L., Kirkwood, C. M., Ding, Y., Schempf, T., Jones-Laughner, J., Kofler, J., Ikonomovic, M. D., Lopez, O. L., Garver, M. E., Fitz, N. F., Koldamova, R., & Yates, N. A.
Venue
Molecular & Cellular Proteomics
Publisher
Elsevier BV
Published
2016-07
Volume
15
Issue
7
Pages
2252-2262
ISSN
1535-9476 (ISSN-L)
OpenAlex
W2482435621
Cited by
37
References
25
FWCI
2.28
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Apolipoprotein E*4 (APOE*4) Genotype Is Associated with Altered Levels of Glutamate Signaling Proteins and Synaptic Coexpression Networks in the Prefrontal Cortex in Mild to Moderate Alzheimer Disease. https://app.cochat.ai/papers/10.1074/mcp.m115.056580
The paper
Sweet, R. A., MacDonald, M. L., Kirkwood, C. M., Ding, Y., Schempf, T., Jones-Laughner, J., Kofler, J., Ikonomovic, M. D., Lopez, O. L., Garver, M. E., Fitz, N. F., Koldamova, R., & Yates, N. A. (2016). Apolipoprotein E*4 (APOE*4) Genotype Is Associated with Altered Levels of Glutamate Signaling Proteins and Synaptic Coexpression Networks in the Prefrontal Cortex in Mild to Moderate Alzheimer Disease. Molecular & Cellular Proteomics. https://doi.org/10.1074/mcp.m115.056580

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.